CLINICAL_TRIALS
trial_result
· 2025-06-12
Clinical Trial Update: HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome [Phase 3]
Summary
Phase 3 trial evaluating hydrocortisone and vasopressin for post-resuscitation syndrome is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Postresuscitation Syndrome | Phase 3 | Status: RECRUITING